Heparin is Not Inferior to Bivalirudin in Percutaneous Coronary Intervention-Focusing on the Effect of Glycoprotein IIb/IIIa Inhibitor Use: A Meta-Analysis.
about
Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisGender Disparity in the Safety and Efficacy of Radial and Femoral Access for Coronary Intervention: A Systematic Review and Meta-Analysis.
P2860
Heparin is Not Inferior to Bivalirudin in Percutaneous Coronary Intervention-Focusing on the Effect of Glycoprotein IIb/IIIa Inhibitor Use: A Meta-Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Heparin is Not Inferior to Biv ...... nhibitor Use: A Meta-Analysis.
@en
type
label
Heparin is Not Inferior to Biv ...... nhibitor Use: A Meta-Analysis.
@en
prefLabel
Heparin is Not Inferior to Biv ...... nhibitor Use: A Meta-Analysis.
@en
P2093
P2860
P356
P1433
P1476
Heparin is Not Inferior to Biv ...... nhibitor Use: A Meta-Analysis.
@en
P2093
Bao-Tao Huang
Chen Zhang
Fang-Yang Huang
Kai-Sen Huang
Peng-Ju Wang
Qing-Tao Meng
P2860
P304
P356
10.1177/0003319715568972
P577
2015-01-29T00:00:00Z